Skip to main content

Balyasny Asset Management L.P.

Position in CTMX — CytomX Therapeutics, Inc.

CIK 1218710 Chicago, IL

Position in CTMX

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$3,434,966
-$13,060,614 QoQ
Shares Held
730,844
-81.1% QoQ
Ownership
0.335%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in CTMX Over Time

Shares Held

Position Value (USD)

Derivatives in CTMX

reported options exposure · as of Dec 31, 2025
CallValue
$3,834,000
CallShares
900,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Balyasny Asset Management L.P. holds $2,350,910,046 across 177 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in CTMX

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,434,966 730,844
2025-12-31 $3,834,000 900,000
2025-12-31 $16,495,580 3,872,202
2025-09-30 $2,871,000 900,000
2025-09-30 $12,482,728 3,913,081
2025-06-30 $6,504,968 2,865,625
2024-03-31 $69,587 31,921
2022-12-31 $55,680 34,800
2022-09-30 $21,451 14,794
2022-06-30 $30,290 16,552
2021-06-30 $63,673 10,059